Mu-opioid and corticotropin-releasing-factor receptors show largely postsynaptic co-expression, and separate presynaptic distributions, in the mouse central amygdala and bed nucleus of the stria terminalis

Neuroscience

Volumn 159, Issue 2, 2009, Pages 526-539

  Jaferi, A ^a   Pickel, V M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

addiction; anxiety; electron microscopic immunolabeling; relapse; stress; withdrawal

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; MU OPIATE RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANTIBODY LABELING; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC SPINE; ELECTRON MICROSCOPY; IMMUNOREACTIVITY; NERVE CELL INHIBITION; NERVE CELL STIMULATION; NERVE FIBER MEMBRANE; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SOMATIC CELL; STRIA TERMINALIS;

AMYGDALA; ANIMALS; AXONS; DENDRITES; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, IMMUNOELECTRON; NEURONS; PRESYNAPTIC TERMINALS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, OPIOID, MU; SEPTAL NUCLEI; SYNAPSES;

EID: 60849087934     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.12.061     Document Type: Article

References (121)

1. Abbadie C., Pan Y.X., and Pasternak G.W. Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-1C-like and MOR-1-like immunoreactivity: evidence for region-specific processing. J Comp Neurol 419 2 (2000) 244-256
2. Arluison M., Brochier G., Vankova M., Leviel V., Villalobos J., and Tramu G. Demonstration of peptidergic afferents to the bed nucleus of the stria terminalis using local injections of colchicine. A combined immunohistochemical and retrograde tracing study. Brain Res Bull 34 4 (1994) 319-337
3. Arvidsson U., Riedl M., Chakrabarti S., Lee J.H., Nakano A.H., Dado R.J., Loh H.H., Law P.Y., Wessendorf M.W., and Elde R. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 15 5 Pt 1 (1995) 3328-3341
4. Bossert J.M., Liu S.Y., Lu L., and Shaham Y. A role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking. J Neurosci 24 47 (2004) 10726-10730
5. Buckingham J.C., and Cooper T.A. Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine. Neuroendocrinology 38 5 (1984) 411-417
6. Cassell M.D., and Gray T.S. Morphology of peptide-immunoreactive neurons in the rat central nucleus of the amygdala. J Comp Neurol 281 2 (1989) 320-333
7. Cassell M.D., Freedman L.J., and Shi C. The intrinsic organization of the central extended amygdala. Ann N Y Acad Sci 877 (1999) 217-241
8. Chan J., Aoki C., and Pickel V.M. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neurosci Methods 33 2-3 (1990) 113-127
9. Chemicon. Guinea-pig anti-μ opioid receptor-1 polyclonal antibody AB1774 product information. Downloaded from (2005). http://www.chemicon.com/webfiles/PDF/AB1774.pdf on 11/26/08
10. Chen Y., Brunson K.L., Muller M.B., Cariaga W., and Baram T.Z. Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus. J Comp Neurol 420 3 (2000) 305-323
11. 5-enkephalin. Brain Res 731 (1996) 141-154
12. Chieng B.C., Christie M.J., and Osbourne P.B. Characterization of neurons in the rat central nucleus of the amygdala: cellular physiology, morphology, and opioid sensitivity. J Comp Neurol 497 6 (2006) 910-927
13. Contarino A., and Papaleo F. The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal. Proc Natl Acad Sci U S A 102 51 (2005) 18649-18654
14. Contet C., Kieffer B.L., and Befort K. Mu opioid receptor: a gateway to drug addiction. Curr Opin Neurobiol 14 3 (2004) 370-378
15. Curtis A.L., Bello N.T., and Valentino R.J. Evidence for functional release of endogenous opioids in the locus ceruleus during stress termination. J Neurosci 21 13 (2001) RC152
16. Day H.E., Curran E.J., Watson Jr. S.J., and Akil H. Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1beta. J Comp Neurol 413 1 (1999) 113-128
17. degli Uberti E.C., Petraglia F., Bondanelli M., Guo A.L., Valentini A., Salvadori S., Criscuolo M., Nappi R.E., and Genazzani A.R. Involvement of mu-opioid receptors in the modulation of pituitary-adrenal axis in normal and stressed rats. J Endocrinol Invest 18 1 (1995) 1-7
18. Delle Donne K.T., Chan J., Boudin H., Pélaprat D., Rostène W., and Pickel V.M. Electron microscopic dual labeling of high-affinity neurotensin and dopamine D2 receptors in the rat nucleus accumbens shell. Synapse 52 3 (2004) 176-187
19. de Olmos J.S., and Heimer L. The concepts of the ventral striatopallidal system and extended amygdala. Ann N Y Acad Sci 877 (1999) 1-32
20. Ding Y.Q., Kaneko T., Nomura S., and Mizuno N. Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. J Comp Neurol 367 3 (1996) 375-402
21. Dong H.W., Petrovich G.D., Watts A.G., and Swanson L.W. Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J Comp Neurol 436 4 (2001) 430-455
22. Dong H.W., and Swanson L.W. Organization of axonal projections from the anterolateral area of the bed nuclei of the stria terminalis. J Comp Neurol 468 2 (2004) 277-298
23. Drake C.T., and Milner T.A. Mu opioid receptors are in discrete hippocampal interneuron subpopulations. Hippocampus 12 2 (2002) 119-136
24. Drolet G., Dumont E.C., Gosselin I., Kinkead R., Laforest S., and Trottier J.F. Role of endogenous opioid system in the regulation of the stress response. Prog Neuropsychopharmacol Biol Psychiatry 25 4 (2001) 729-741
25. Duman R.S., Tallman J.F., and Nestler E.J. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J Pharmacol Exp Ther 246 3 (1988) 1033-1039
26. Erb S., Salmaso N., Rodaros D., and Stewart J. A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 158 4 (2001) 360-365
27. Farb C., Aoki C., Milner T., Kaneko T., and LeDoux J. Glutamate immunoreactive terminals in the lateral amygdaloid nucleus: a possible substrate for emotional memory. Brain Res 593 2 (1992) 145-158
28. Frassoni C., Spreafico R., and Bentivoglio M. Glutamate, aspartate and co-localization with calbindin in the medial thalamus. An immunohistochemical study in the rat. Exp Brain Res 115 1 (1997) 95-104
29. Fu Y., and Neugebauer V. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. J Neurosci 28 15 (2008) 3861-3876
30. Garzon M., and Pickel V.M. Ultrastructural localization of enkephalin and mu-opioid receptors in the rat ventral tegmental area. Neuroscience 114 2 (2002) 461-474
31. Georges F., and Aston-Jones G. Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J Neurosci 22 12 (2002) 5173-5187
32. González P., Cabello P., Germany A., Norris B., and Contreras E. Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists. Eur J Pharmacol 332 3 (1997) 257-262
33. Grammatopoulos D.K., Randeva H.S., Levine M.A., Kanellopoulou K.A., and Hillhouse E.W. Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J Neurochem 76 2 (2001) 509-519
34. Gray T.S., and Magnuson D.J. Neuropeptide neuronal efferents from the bed nucleus of the stria terminalis and central amygdaloid nucleus to the dorsal vagal complex in the rat. J Comp Neurol 262 3 (1987) 365-374
35. Gray T.S., and Magnuson D.J. Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides 13 3 (1992) 451-460
36. Gray T.S. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann N Y Acad Sci 697 (1993) 53-60
37. Han Z.S., and Ju G. Effects of electrical stimulation of the central nucleus of the amygdala and the lateral hypothalamic area on the oval nucleus of the bed nucleus of the stria terminalis and its adjacent areas in the rat. Brain Res 536 (1990) 56-62
38. Hara Y., and Pickel V.M. Overlapping intracellular and differential synaptic distributions of dopamine D1 and glutamate N-methyl-D-aspartate receptors in rat nucleus accumbens. J Comp Neurol 492 4 (2005) 442-455
39. Harris G.C., and Aston-Jones G. Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal. Behav Brain Res 176 2 (2007) 251-258
40. Heinrichs S.C., Menzaghi F., Schulteis G., Koob G.F., and Stinus L. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol 6 1 (1995) 74-80
41. Hof P.R., Young W.G., Bloom F.E., Belichenko P.V., and Celio M.R. Comparative cytoarchitectonic atlas of the C57BL/6 and 129/Sv mouse brains (2000), Elsevier Science, Amsterdam
42. Huang J., and Pickel V.M. Ultrastructural localization of serotonin 2A and N-methyl-D-aspartate receptors in somata and dendrites of single neurons within rat dorsal motor nucleus of the vagus. J Comp Neurol 455 2 (2003) 270-280
43. Iredale P.A., Alvaro J.D., Lee Y., Terwilliger R., Chen Y.L., and Duman R.S. Role of corticotropin-releasing factor receptor-1 in opiate withdrawal. J Neurochem 74 1 (2000) 199-208
44. Jaferi A., and Bhatnagar S. Corticosterone can act at the posterior paraventricular thalamus to inhibit hypothalamic-pituitary-adrenal activity in animals that habituate to repeated stress. Endocrinology 147 10 (2006) 4917-4930
45. Janssens C.J., Helmond F.A., Loyens L.W., Schouten W.G., and Wiegant V.M. Chronic stress increases the opioid-mediated inhibition of the pituitary-adrenocortical response to acute stress in pigs. Endocrinology 136 4 (1995) 1468-1473
46. Keck M.E., Ohl F., Holsboer F., and Müller M.B. Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders. Neurosci Biobehav Rev 29 4-5 (2005) 867-889
47. Kieffer B.L., and Gavériaux-Ruff C. Exploring the opioid system by gene knockout. Prog Neurobiol 66 5 (2002) 285-306
48. Koob G.F. Neuroadaptive mechanisms of addiction: studies on the extended amygdala. Eur Neuropsychopharmacol 13 6 (2003) 442-452
49. Koob G., and Kreek M.J. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164 8 (2007) 1149-1159
50. LaLumiere R.T., and Kalivas P.W. Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci 28 12 (2008) 3170-3177
51. Lane D.A., Lessard A.A., Chan J., Colago E.E., Zhou Y., Schlussman S.D., Kreek M.J., and Pickel V.M. Region-specific changes in the subcellular distribution of AMPA receptor GluR1 subunit in the rat ventral tegmental area after acute or chronic morphine administration. J Neurosci 28 39 (2008) 9670-9681
52. Li S., and Kirouac G.J. Projections from the paraventricular nucleus of the thalamus to the forebrain, with special emphasis on the extended amygdala. J Comp Neurol 506 2 (2008) 263-287
53. Liberzon I., Zubieta J.K., Fig L.M., Phan K.L., Koeppe R.A., and Taylor S.F. mu-Opioid receptors and limbic responses to aversive emotional stimuli. Proc Natl Acad Sci U S A 99 10 (2002) 7084-7089
54. Liu J., Yu B., Neugebauer V., Grigoriadis D.E., Rivier J., Vale W.W., and Shinnick-Gallagher J.P. Corticotropin-releasing factor and urocortin I modulate excitatory glutamatergic synaptic transmission. J Neurosci 24 16 (2004) 4020-4029
55. Lopez de Armentia M., and Sah P. Bidirectional synaptic plasticity at nociceptive afferents in the rat central amygdala. J Physiol 581 Pt 3 (2007) 961-970
56. Lu L., Liu D., Ceng X., and Ma L. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence. Eur J Neurosci 12 12 (2000) 4398-4404
57. Mansour A., Khachaturian H., Lewis M.E., Akil H., and Watson S.J. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7 8 (1987) 2445-2464
58. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., and Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350 3 (1994) 412-438
59. Mansour A., Fox C.A., Burke S., Akil H., and Watson S.J. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J Chem Neuroanat 8 4 (1995) 283-305
60. Marchant N.J., Densmore V.S., and Osbourne P.B. Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: Evidence of two distinct endogenous opioid systems in the lateral division. J Comp Neurol 504 6 (2007) 702-715
61. Marson L., Kiritsy-Roy J.A., and Van Loon G.R. mu-Opioid peptide modulation of cardiovascular and sympathoadrenal responses to stress. Am J Physiol 257 4 Pt 2 (1989) R901-R908
62. McCubbin J.A. Stress and endogenous opioids: behavioral and circulatory interactions. Biol Psychol 35 2 (1993) 91-122
63. McCubbin J.A., Kaplan J.R., Manuck S.B., and Adams M.R. Opioidergic inhibition of circulatory and endocrine stress responses in cynomolgus monkeys: a preliminary study. Psychosom Med 55 1 (1993) 23-28
64. McDonald A.J., Shammah-Lagnado S.J., Shi C., and Davis M. Cortical afferents to the extended amygdala. Ann N Y Acad Sci 877 (1999) 309-338
65. Moga M.M., and Gray T.S. Evidence for corticotropin-releasing factor, neurotensin, and somatostatin in the neural pathway from the central nucleus of the amygdala to the parabrachial nucleus. J Comp Neurol 241 3 (1985) 275-284
66. Moga M.M., Saper C.B., and Gray T.S. Bed nucleus of the stria terminalis: cytoarchitecture, immunohistochemistry, and projection to the parabrachial nucleus in the rat. J Comp Neurol 283 3 (1989) 315-332
67. Moriwaki A., Wang J.B., Svingos A., van Bockstaele E., Cheng P., Pickel V., and Uhl G.R. mu Opiate receptor immunoreactivity in rat central nervous system. Neurochem Res 21 11 (1996) 1315-1331
68. Morris M., Salmon P., Steinberg H., Sykes E.A., Bouloux P., Newbould E., McLoughlin L., Besser G.M., and Grossman A. Endogenous opioids modulate the cardiovascular response to mental stress. Psychoneuroendocrinology 15 3 (1990) 185-192
69. Moskowitz A.S., and Goodman R.R. Light microscopic autoradiographic localization of mu and delta opioid binding sites in the mouse central nervous system. J Neurosci 4 5 (1984) 1331-1342
70. Nakagawa T., Yamamoto R., Fujio M., Suzuki Y., Minami M., Satoh M., and Kaneko S. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats. Neuroscience 134 1 (2005) 9-19
71. Nestler E.J. Under siege: the brain on opiates. Neuron 16 5 (1996) 897-900
72. Nirenberg M.J., Liu Y., Peter D., Edwards R.H., and Pickel V.M. The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. Proc Natl Acad Sci U S A 92 19 (1995) 8773-8777
73. Orozco-Cabal L., Liu J., Pollandt S., Schmidt K., Shinnick-Gallagher P., and Gallagher J.P. Dopamine and corticotropin-releasing factor synergistically alter basolateral amygdala-to-medial prefrontal cortex synaptic transmission: functional switch after chronic cocaine administration. J Neurosci 28 2 (2008) 529-542
74. Peters A., Palay S.L., and Webster H.D. The fine structure of the nervous system (1991), Oxford University Press, New York
75. Peters A., and Palay S.L. The morphology of synapses. J Neurocytol 25 12 (1996) 687-700
76. Phelix C.F., and Paull W.K. Demonstration of distinct corticotropin releasing factor-containing neuron populations in the bed nucleus of the stria terminalis. A light and electron microscopic immunocytochemical study in the rat. Histochemistry 94 4 (1990) 345-364
77. Pickel V.M., Chan J., Kash T.L., Rodríguez J.J., and MacKie K. Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience 127 1 (2004) 101-112
78. Pickel V.M., Chan J., Kearn C.S., and Mackie K. Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. J Comp Neurol 495 3 (2006) 299-313
79. Poulin J.F., Chevalier B., Laforest S., and Drolet G. Enkephalinergic afferents of the centromedial amygdala in the rat. J Comp Neurol 496 6 (2006) 859-876
80. Rainnie D.G., Bergeron R., Sajdyk T.J., Patil M., Gehlert D.R., and Shekar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci 24 14 (2004) 3471-3479
81. Reyes B.A., Valentino R.J., and Van Bockstaele E.J. Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology 149 1 (2008) 122-130
82. Reynolds E.S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17 (1963) 208-212
83. Ribeiro S.C., Kennedy S.E., Smith Y.R., Stohler C.S., and Zubieta J.K. Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors. Prog Neuropsychopharmacol Biol Psychiatry 29 8 (2005) 1264-1280
84. Rodaros D., Caruana D.A., Amir S., and Stewart J. Corticotropin-releasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area. Neuroscience 150 1 (2007) 8-13
85. Roder S., and Ciriello J. Contribution of bed nucleus of the stria terminalis to the cardiovascular responses elicited by stimulation of the amygdala. J Auton Nerv Syst 45 1 (1993) 61-75
86. Rodriguez J.J., Mackie K., and Pickel V.M. Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat caudate putamen nucleus. J Neurosci 21 3 (2001) 823-833
87. Sakanaka M., Shibasaki T., and Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res 382 (1986) 213-238
88. Schmued L.C. Diagonal ventral forebrain continuum has overlapping telencephalic inputs and brainstem outputs which may represent loci for limbic/autonomic integration. Brain Res 667 2 (1994) 175-191
89. Sesack S.R., and Pickel V.M. Ultrastructural relationships between terminals immunoreactive for enkephalin, GABA, or both transmitters in the rat ventral tegmental area. Brain Res 672 1-2 (1995) 261-275
90. Shaham Y., Funk D., Erb S., Brown T.J., Walker C.D., and Stewart J. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci 17 7 (1997) 2605-2614
91. Shaham Y., Erb S., Leung S., Buczek Y., and Stewart J. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology (Berl) 137 2 (1998) 184-190
92. Shammah-Lagnado S.J., Beltramino C.A., McDonald A.J., Miselis R.R., Yang M., de Olmos J., Heimer L., and Alheid G.F. Supracapsular bed nucleus of the stria terminalis contains central and medial extended amygdala elements: evidence from anterograde and retrograde tracing experiments in the rat. J Comp Neurol 422 4 (2000) 533-555
93. Shimada S., Inagaki S., Kubota Y., Ogawa N., Shibasaki T., and Takagi H. Coexistence of peptides (corticotropin releasing factor/neurotensin and substance P/somatostatin) in the bed nucleus of the stria terminalis and central amygdaloid nucleus of the rat. Neuroscience 30 2 (1989) 377-383
94. Skelton K.H., Oren D., Gutman D.A., Easterling K., Holtzman S.G., Nemeroff C.B., and Owens M.J. The CRF(1) receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal. Eur J Pharmacol 571 1 (2007) 17-24
95. Stinus L., Cador M., Zorrilla E.P., and Koob G.F. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Neuropsychopharmacology 30 1 (2005) 90-98
96. Sufka K.J., Hughes R.A., McCormick T.M., and Borland J.L. Opiate effects on isolation stress in domestic fowl. Pharmacol Biochem Behav 49 4 (1994) 1011-1015
97. Sun N., Roberts L., and Cassell M.D. Rat central amygdaloid nucleus projections to the bed nucleus of the stria terminalis. Brain Res Bull 27 5 (1991) 651-662
98. Sun N., and Cassell M.D. Intrinsic GABAergic neurons in the rat central extended amygdala. J Comp Neurol 330 3 (1993) 381-404
99. 5-enkephalin. J Neurosci 16 (1996) 4162-4173
100. Swanson L.W., Sawchenko P.E., Rivier J., and Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36 3 (1983) 165-186
101. Terwilliger R.Z., Beitner-Johnson D., Sevarino K.A., Crain S.M., and Nestler E.J. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548 1-2 (1991) 100-110
102. Torrealba F., and Carrasco M.A. A review on electron microscopy and neurotransmitter systems. Brain Res Brain Res Rev 47 1-3 (2004) 5-17
103. Treweek J.B., Jaferi A., Colago E.E., Zhou P., and Pickel V.M. Electron microscopic localization of corticotropin releasing factor (CRF) and CRF receptor in rat and mouse central nucleus of the amygdala. J Comp Neurol 512 3 (2009) 323-335
104. Ueda H., Harada H., Nozaki M., Katada T., Ui M., Satoh M., and Takagi H. Reconstitution of rat brain mu opioid receptors with purified guanine nucleotide-binding regulatory proteins, Gi and Go. Proc Natl Acad Sci U S A 85 18 (1988) 7013-7017
105. Uryu K., Okumura T., Shibasaki T., and Sakanaka M. Fine structure and possible origins of nerve fibers with corticotropin-releasing factor-like immunoreactivity in the rat central amygdaloid nucleus. Brain Res 577 1 (1992) 175-179
106. Valentino R.J., and Van Bockstaele E. Opposing regulation of the locus coeruleus by corticotropin-releasing factor and opioids. Potential for reciprocal interactions between stress and opioid sensitivity. Psychopharmacology (Berl) 158 4 (2001) 331-342
107. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., and Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428 2 (2000) 191-212
108. Veinante P., and Freund-Mercier M.J. Intrinsic and extrinsic connections of the rat central extended amygdala: an in vivo electrophysiological study of the central amygdaloid nucleus. Brain Res 794 2 (1998) 188-198
109. Veinante P., Stoeckel M., Lasbennes F., and Freund-Mercier M.J. c-Fos and peptide immunoreactivities in the central extended amygdala of morphine-dependent rats after naloxone-precipitated withdrawal. Eur J Neurosci 18 5 (2003) 1295-1305
110. Walker D.L., Toufexis D.J., and Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 463 1-3 (2003) 199-216
111. Walker D.L., and Davis M. Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer. Brain Struct Funct (2008) DOI 10.1007/s00429-008-0183-3
112. Wang H., Moriwaki A., Wang J.B., Uhl G.R., and Pickel V.M. Ultrastructural immunocytochemical localization of mu opioid receptors and Leu5-enkephalin in the patch compartment of the rat caudate-putamen nucleus. J Comp Neurol 375 4 (1996) 659-674
113. Wang H., Gracy K.N., and Pickel V.M. Mu-opioid and NMDA-type glutamate receptors are often colocalized in spiny neurons within patches of the caudate-putamen nucleus. J Comp Neurol 412 1 (1999) 132-146
114. Wang H., and Pickel V.M. Preferential cytoplasmic localization of delta-opioid receptors in rat striatal patches: comparison with plasmalemmal mu-opioid receptors. J Neurosci 21 9 (2001) 3242-3250
115. Wang H., and Pickel V.M. Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J Comp Neurol 442 4 (2002) 392-404
116. Wang J., Fang Q., Liu Z., and Lu L. Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Psychopharmacology (Berl) 185 1 (2006) 19-28
117. Watanabe T., Nakagawa T., Yamamoto R., Maeda A., Minami M., and Satoh M. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn J Pharmacol 88 (2002) 399-406
118. Xu G., Van Bockstaele E., Reyes B., Bethea T., and Valentino R.J. Chronic morphine sensitizes the brain norepinephrine system to corticotropin-releasing factor and stress. J Neurosci 24 38 (2004) 8193-8197
119. Yasui Y., Breder C.D., Saper C.B., and Cechetto D.F.A. Autonomic responses and efferent pathways from the insular cortex in the rat. J Comp Neurol 303 (1991) 355-374
120. Zhu W., and Pan Z.Z. Synaptic properties and postsynaptic opioid effects in rat central amygdala neurons. Neuroscience 127 4 (2004) 871-879
121. Zhu W., and Pan Z.Z. Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons. Neuroscience 133 1 (2005) 97-103